First Tracks Biotherapeutics (TRAX) Stock Insights
$1.64B
Market Cap
-12.57
P/E
—
Forward P/E
61
Score
TRAX price $45.72 +0.34 +0.75%
Stocklytics score rationale: value 34, quality 52, growth 98.
| 2023 | 2024 | 2025 |
|---|---|---|
| 0 | 0 | 0 |
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
TRAX fair value Not meaningful. Price $45.72.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.92 | — | — |
| 2026-08-12 | -0.95 | -0.80 | — | 75.00M |
| 2026-05-14 | -1.45 | -0.98 | — | 22.26M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Orwin John A | Buy | 1.30K | — | — |
| 2026-09-15 | Orwin John A | Sell | 1.30K | — | — |
| 2026-09-02 | Ware J. Anthony | Buy | 39.27K | $5.74 | 225.38K |
| 2026-09-02 | Ware J. Anthony | Sell | 39.27K | $44.78 | 1.76M |
| 2026-09-02 | Ware J. Anthony | Sell | 28.57K | $5.74 | 164.00K |
| 2026-09-02 | Ware J. Anthony | Sell | 10.69K | $5.74 | 61.38K |
| 2026-08-15 | STONE BENJAMIN | Buy | 60.49K | — | — |
| 2026-08-15 | Lizzul Paul F. | Buy | 60.49K | — | — |
| 2026-08-15 | Faga Daniel | Buy | 193.57K | — | — |
| 2026-08-02 | STONE BENJAMIN | Buy | 60.49K | — | — |
| 2026-08-02 | Lizzul Paul F. | Buy | 60.49K | — | — |
| 2026-08-02 | Faga Daniel | Buy | 193.58K | — | — |
| 2026-04-20 | Lizzul Paul F. | Other | 16.67K | — | — |
| 2026-04-20 | STONE BENJAMIN | Other | 16.67K | — | — |
| 2026-04-20 | Faga Daniel | Other | 53.33K | — | — |
| 2026-04-20 | ANAPTYSBIO, INC | Sell | 100 | — | — |
| 2026-04-01 | ANAPTYSBIO, INC | Other | 0 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 153. Ownership 98.85%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 3.17M | New | New | 63.87M |
| TCG CROSSOVER MANAGEMENT, LLC | 2.90M | New | New | 58.25M |
| FMR LLC | 2.05M | New | New | 41.33M |
| AFFINITY ASSET ADVISORS, LLC | 2.03M | New | New | 40.88M |
| BLACKROCK, INC. | 1.96M | New | New | 39.51M |
| TRAILS EDGE CAPITAL PARTNERS, LP | 1.51M | New | New | 30.46M |
| STATE STREET CORP | 1.51M | New | New | 30.44M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.45M | New | New | 29.21M |
| JUPITER TOPCO LLC | 1.09M | New | New | 21.96M |
| VESTAL POINT CAPITAL, LP | 1.01M | New | New | 20.38M |
| WOODLINE PARTNERS LP | 917.18K | New | New | 18.45M |
| SANOFI | 821.92K | New | New | 16.54M |
| MORGAN STANLEY | 781.53K | New | New | 15.72M |
| 683 CAPITAL MANAGEMENT, LLC | 750.00K | New | New | 15.09M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 729.00K | New | New | 14.67M |
| BALYASNY ASSET MANAGEMENT L.P. | 714.95K | New | New | 14.38M |
| GEODE CAPITAL MANAGEMENT, LLC | 702.09K | New | New | 14.13M |
| BANK OF AMERICA CORP /DE/ | 647.96K | New | New | 13.04M |
| STEMPOINT CAPITAL LP | 622.72K | New | New | 12.53M |
| PALO ALTO INVESTORS LP | 603.49K | New | New | 12.14M |
| SOFINNOVA INVESTMENTS, INC. | 565.20K | New | New | 11.37M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 546.99K | New | New | 11.01M |
| GOLDMAN SACHS GROUP INC | 487.21K | New | New | 9.80M |
| POINT72 ASSET MANAGEMENT, L.P. | 408.33K | New | New | 8.22M |
| UBS GROUP AG | 310.89K | New | New | 6.26M |
Insights · Dividends · Forecast · Financials · Learn
$1.64B
Market Cap
-12.57
P/E
—
Forward P/E
61
Score